Navigation Links
As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention

$11 Million in New Projects Approved in Atlanta

ATLANTA, May 19 /PRNewswire-USNewswire/ -- Meeting at the world's largest bioscience and biotechnology convention, the Kansas Bioscience Authority has approved more than $11 million in new investments as part of a $581 million initiative to help researchers and businesses thrive in the state.

The funding decisions made at the Bio International Convention will create bioscience centers of innovation in biomaterials and plant biology, expand cancer drug development efforts, and create a strong bioenergy research partnership between the University of Kansas and the Archer Daniels Midland Company.

Centers of innovation

The Kansas Innovation Center for Advanced Plant Design will receive

$4 million over two years to develop advanced technologies for gene discovery, trait validation and crop improvement in order to deliver new products and production platforms. The global research team associated with the center will focus on emerging commercial opportunities for wheat and sorghum, crops in which Kansas has world- renowned leadership and expertise.

The center is a public and private collaboration of Kansas Wheat, Kansas State University, the University of Kansas, and many private investors. Within 10 years, the center is projected to create 36 patents, 20 commercial start-ups and 285 jobs.

The KBA also will invest $4 million in the Center of Innovation for Biomaterials in Orthopaedic Research to create medical instruments, medical devices, and composite implants that will improve the practice of orthopedic medicine. The center will focus on commercial viability, conducting research requested by industry to meet market needs and capitalizing on the concentration of composites expertise found in Wichita due to the state's longstanding aviation industry leadership.

Partnering to form this center are Wichita State University, the National Institute of Aviation Research, the Wichita Composites Advisory Board, Kansas State University, Pittsburg State University, and Via Christi Health. It is expected to increase employment in Kansas by 2,000 over 10 years.

This brings the number of approved centers of innovation to four after the March approval of the Kansas Bioscience Innovation Center in Drug Delivery and Kansas Bioenergy and Biorefining Center of Innovation.

Cancer drug development

Adding to the investment of more than $32 million in drug discovery and delivery projects in March, the KBA is committing another $1.9 million this month:

  • Lenexa-based CyDex Pharmaceuticals will receive $195,000 to commercialize re-formulated drugs that address limitations of existing therapies. A focus will be improving a cancer drug for patients with multiple myeloma (cancer of the Plasma B cells formed in the bone marrow).

  • CritiTech and SCF Technologies of Lawrence were awarded $50,000 to further develop a novel approach to converting drugs into dry, sterile powder form. The process is expected to significantly reduce costs in drug manufacturing, while easing the process of administering drugs for both physicians and patients. The investment is a partial match to a $100,000 grant from the National Cancer Institute.

  • Manhattan-based NanoScale will use $50,000 in KBA matching funds to expedite the testing of nanoparticles for diagnostic and therapeutic uses in fighting cancer. These "stealth" particles are expected to allow earlier disease detection and to improve the ability of drugs to hit their intended targets with fewer side effects. The company received a $150,000 Small Business Innovation Research award from the National Institutes of Health.

  • A $500,000 Collaborative Cancer Research Initiative (CCRI) investment will go to the University of Kansas Cancer Center and Scripps Research Institute. The research is intended to reduce the unwanted toxicity often associated with chemotherapy and improve the treatment of breast and prostate cancers.

  • A second $500,000 CCRI investment was approved to initiate Phase I clinical trials in the Wichita area through a partnership of the University of Kansas Cancer Center, Cancer Center of Kansas, Midwest Cancer Alliance and Via Christi Regional Medical Center. Phase I trials will complement the successful Phase II and III programs in Wichita and strengthen rural and regional treatment options.

  • A $600,000 project budget was committed for the KBA to support the University of Kansas Cancer Center's efforts to bring cutting-edge cancer treatments closer to home for millions of Kansans through National Cancer Institute designation.

Bioenergy research partnership

The KBA will provide $1.2 million over three years for bioenergy research at the University of Kansas Center for Environmentally Beneficial Catalysis as a match to $1.2 million being invested by Archer Daniels Midland Company, which operates five processing plants, a technical center, and sales and distribution offices throughout Kansas. Research will focus on converting multiple feedstocks, including biomass, into a wide platform of fuels and chemicals to replace or improve upon petroleum-based products. The university will provide in-kind support valued at more than $334,000.

Approved investments are subject to final agreements between the KBA and investees.

About the KBA

The Kansas Bioscience Authority is a $581-million initiative created by the Kansas Economic Growth Act of 2004 to expand the state's world-class research capacity and bioscience clusters; support the growth of bioscience startups; and stimulate bioscience business expansion and attraction.

SOURCE Kansas Bioscience Authority
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Fifth Annual SemTech Conference Highlights How Semantics Power Chemistry, Pharmaceutical, Healthcare, and Other Life Science Solutions
2. The first DFG research centers to be funded for another 4 years
3. Disabled and other vulnerable groups more susceptible to terrorism fears
4. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
5. Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth
6. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
7. Immunotherapy-Based Provisional Patents Mark Significant Discovery
8. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
9. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
10. Patent for Making Combination Chemotherapy Work Better
11. Oxygen Biotherapeutics, Inc. Expands Board of Directors
Post Your Comments:
(Date:10/8/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, today announced its schedule of ... in the month of October: Stem Cell ... will be presenting at the annual Partnering Forum, part ... be held October 7-9 in La Jolla, ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis (CF) is ... (CFTR) gene and results in dysfunction of the lungs and the gastrointestinal (GI) ... This mucus is very difficult to clear, blocks the airways and the glands, ...
(Date:10/7/2015)...  ChromaDex Corp. (OTCQX: CDXC), an innovator of ... science-based solutions for dietary supplement, food and beverage, ... announced that the October 1 presentation from ... available for on-demand viewing at ...   --> LINK: ...
(Date:10/7/2015)... Md. , Oct. 7, 2015   Intrexon ... synthetic biology, today announced it will hold an Investor ... on the afternoon of Thursday, November 12, 2015. Intrexon,s ... and other members of the Company,s management team ... including a focus on strategic initiatives, product pipeline, and ...
Breaking Biology Technology:
... was at a security conference and stayed at a hotel, ... claimed that they had implemented it so only those on ... ,I do not purchase wireless Internet service when Im at ... the seminar hosts office. Out of curiosity, on my second ...
... Commerce has announced that it is producing the Wisconsin ... Thursday, September 25, from 8:30 a.m. to 3:45 p.m. ... , ,Wisconsins medical device and technology cluster is ... state, said Department of Commerce (Commerce) Secretary Cory L. ...
... all things e-commerce will speak to cutting-edge Madisonians Thursday evening ... Club Majestic, 115 King Street in downtown Madison. , ,Nationally ... about how e-commerce is coming out of the weeds after ... Some companies are finally learning how to please consumers and ...
Cached Biology Technology:
(Date:9/10/2015)... LONDON , Sept. 10, 2015 Report ... thus far not quite delivered upon previous expectations of ... might be the breakthrough year in which wearables begin ... been expected. One of the main reasons is the ... disrupt not only the SmartWatches market, but the overall ...
(Date:9/8/2015)... , Sept. 8, 2015   TREW Marketing ... new survey, Smart Marketing for Engineers TM : ... engineering professionals reveals insightful findings about engineers, preferences for ... of content engineers most value and trust, and where ... Marketers targeting technical audiences grapple with how to best ...
(Date:9/2/2015)... Biometric technology ... system which uses identical human characteristic such as ... and finger print. Increasing number of terror attacks ... which provides high level of security. Traditional security ... are vulnerable to attacks. Furthermore, Biometric technology uses ...
Breaking Biology News(10 mins):
... adults living closer to a fast food restaurant had a ... away from fast food, according to researchers at The University ... particularly strong among those with a lower income. ... of Public Health indicates higher BMI associates with residential ...
... relationship between the heritable risk for schizophrenia and low ... associated with cognitive impairments that may cause functional disability. ... to the risk for developing schizophrenia. For example, reduced ... Also, these deficits may be present in healthy relatives ...
... hematopoiesis at sites outside the bone marrow in ... (LMU) in Munich now show that a specific type ... blood cells. Balanced hematopoiesis is essential for the ... takes place mainly in the liver and the spleen. ...
Cached Biology News:
Request Info...
... digests duplex DNA in a 3'-> 5' ... nick, producing stretches of single-stranded DNA. Under ... III proceeds at a uniform rate yielding ... of exonucleolytic excision of deoxyribonucleotides by Exonuclease ...
Mouse monoclonal [HL-37] to HLA DQ1 + HLA DQ3 ( Abpromise for all tested applications)....
Biology Products: